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INTERACTION OF ADIPOSE-DERIVED STEM CELLS                                             




The need for joint replacement will continue to grow and increase significantly in 
the coming decades due to the aging population. Unfortunately, many joint implants 
experience failure after 10-15 years requiring revision surgery. With the growing need for 
more implants and the high cost of medical expenses for orthopedic surgery, it is 
imperative that implants are effective and have long term success. Since joint implant 
materials come into direct contact with bone it is vital that they mimic the structure of bone 
to improve osseointegration, or the direct structural and functional connection between 
living bone and the implant surface. Improving the osseointegration of the implant can 
increase the stability of the implant, thus, reducing micro motions that cause loosening 
and lead to implant failure. Current joint implants have microscale coatings and texturing, 
however, bone is composed of both micro and nano components.  In order to mimic the 
nanostructure of bone, different nanotopograhies are currently being studied. These 
nanostructures have been shown to improve cellular response in terms of adhesion, 
proliferation, and osteogenic differentiation. However, the optimal size of nanosurfaces to 
promote cell adhesion, proliferation, and differentiation is still disputed. Titania nanotubes 
(NT) have been shown to improve cellular response in vitro and improve integration in in 
vivo animal studies.  This thesis investigates the surface characteristics of titania NT and 
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the effect of nanotube size on adhesion, proliferation, and differentiation of adipose-
derived stem cells (ADSC) in vitro. The results presented in this thesis indicate that ADSC 
differentiated and performed better on NT surfaces than Ti surfaces. Additionally, the size 
of titania NT altered the proliferation and osteogenic differentiation of ADSC. Further 
studies should be directed toward in vivo animal studies to confirm that implants with NT 
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Fundamental Hypothesis: Titania nanotube surfaces with different diameters will affect 
stem cell adhesion, proliferation, and differentiation.  
 
Sub Hypothesis 1: Titania nanotube surfaces can be fabricated in different nanotube 
sizes by varying the voltage during anodization. 
Specific Aim 1: Fabrication and characterization of titania nanotube surfaces. This 
specific aim will be discussed in chapter 2 and will cover the following: 
 (a) Fabrication of nanotubes surfaces with three different diameter sizes using 
an electrochemical anodization process. 
 (b) Characterization of nanotube and titanium surfaces by evaluating tube size, 
surface wettability, crystalline structure, and chemical composition. 
 
Sub Hypothesis 2: Titania nanotube surfaces can affect the adhesion and proliferation 
of adipose-derived stem cells. 
Specific Aim 2: Investigate adipose-derived stem cell (ADSC) adhesion and proliferation 
on nanotube and titanium surfaces. This specific aim will be discussed in chapters 3 and 
will cover the following: 
(a) Evaluation of ADSC viability via alamarBlue reduction. 
(b) Evaluation of ADSC adhesion and proliferation via fluorescent staining and 
DAPI cell count.  
(c) Evaluation of ADSC morphology via scanning electron microscopy. 
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Sub hypothesis 3: Titania nanotube surfaces can affect the differentiation response of 
adipose-derived stem cells. 
Specific Aim 3: Investigate adipose-derived stem cell (ADSC) differentiation on 
nanotube surfaces. This specific aim will be discussed in chapter 4 and will cover the 
following: 
(a) Evaluation of ADSC alkaline phosphatase activity. 
(b) Evaluation of non-collagen protein osteocalcin produced by ADSC.  
(c) Evaluation of calcium deposition from ADSC. 
(d) Evaluation of ADSC morphology and mineral deposition via 
immunofluorescence staining and scanning electron microscopy. 
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The adult human body has 206 bones that provide mechanical support, protect 
various organs, and perform metabolic functions such as storing calcium, phosphorus, 
and other essential ions to be used by the body. Strong, healthy bones are essential, but 
bones will become weak and brittle when affected by injury, disease, or just simply age.  
The number of orthopedic implants needed in the United States will increase dramatically 
over the next few decades largely due to growth of the older population. In 2050, the 
population aged 65 and over is projected to be 83.7 million, and by 2030, more than 20 
percent of U.S. residents are projected to be aged 65 and over, compared with 13 percent 
in 2010 and 9.8 percent in 1970 [1]. Additionally, the average body mass index in the 
united states is also increasing and studies are showing a potential correlation between 
high body mass index and joint replacement [2,3]. Already there are many people living 
with a joint implant. A study estimated in 2010 there were 4.5 million people living with an 
artificial hip and 6.7 million people living with an artificial knee in the United States [4].  
Because hip and knee joints often experience failure after 10-15 years, revision surgeries 
for total hip and knee replacement from 2012 to 2015 ranged from 9.9% to 10.4% (hips) 
and 7.2% to 9.4% (knees) [5].   The cost of implant surgery and revision surgery is a 
major concern for the patients and hospitals.  The national average price for just the 
implant in a total knee replacement was $16,109 in 2016 [6].  Revision surgery implants 
for knees can cost $7498 (for one component) up to $13,640 (for all three components) 
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and implant costs are typically only 25-35% of the total hospital bill [6]. With the growing 
need for more implants and the high cost of medical expenses for orthopedic surgery, it 
is imperative that implants are effective and have long term success.   
 
1.2 Titanium as a Material for Orthopedic Implants  
Titanium (Ti) and its alloys are widely used in dental, orthopedic, and 
reconstructive surgery implants [7] due their biocompatible properties. Biocompatibility is 
a term that has been redefined and debated over the last few decades. As biomaterials 
are being used in increasingly diverse and complex situations, with applications now 
involving tissue engineering, invasive sensors, drug delivery, nanotechnologies, and 
implantable medical devices, the definition of biocompatible is becoming increasingly 
more complicated. Williams defined biocompatibility as the “ability of a biomaterial to 
perform its desired function with respect to a medical therapy, without eliciting any 
undesirable local or systemic effects in the recipient or beneficiary of that therapy, but 
generating the most appropriate beneficial cellular or tissue response in that specific 
situation, and optimizing the clinically relevant performance of that therapy” [8].  
Titanium is considered biocompatible in bone applications because it does not 
react to the surrounding tissue (bio inert) due to its inherent corrosion resistance. Ti 
exhibits corrosion resistance because an inert oxide layer spontaneously forms on the 
surface of Ti when it is exposed to oxygen.  This oxide film is very stable and does not 
break down under normal physiological conditions, thus, it provides a protective layer for 
the Ti. Titanium also displays other desirable properties that make is suitable for 
orthopedic applications: high specific strength, low elastic modulus, low density, and 
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fatigue strength [7,8]. The low elastic modulus of titanium and its alloys range from 55-
110 GPa and this is generally viewed as a biomechanical advantage as it is much smaller 
than cobalt–chromium–molybdenum alloy (200-230 GPa) or stainless steel (~200 GPa) 
[7,9], which are other metals commonly used in orthopedic implants. For comparison, the 
elastic modulus of cortical bone ranges between 6-20 GPa [10], thus, titanium implants 
display smaller stress shielding than other metals due to their elastic modulus being 
closer to that of bone [7,9,11].  Commercially pure Ti (CP Ti, grade 2 and 4) and Ti-6Al-
4V (grade 5) alloy are the most common titanium alloys used in orthopedic implants today 
[11,12].  Even though Ti possesses a lot of biocompatible properties that are desirable in 
orthopedic applications, its bone-binding activity is pretty low compared to other materials 
like calcium phosphates [10].  This limitation of Ti negatively affects its biological 
performance and leads to poor anchorage of bone which then leads to decelerated bone 
regeneration and healing after implantation.  
Although Ti implants have improved over the years, they still experience a degree 
of failure when implanted due to mechanical issues [13,14], biological issues [15,16], or 
a combination of both. Titanium is commonly used in the fabrication of the acetabular 
shell and/or the femoral stem in hip implants and the stemmed tibial plate in knee implants 
(Figure 1.1). Although companies have been improving these particular joint implants, 
many of them will still experience failure between 10-30 years resulting in revision surgery 
[17].  The most common cause for failure of knee and hip implants is impaired implant 
fixation, called aseptic loosening [18,19]. It is not entirely sure what causes aseptic 
loosening, but it is likely due to inadequate initial fixation, mechanical loss of fixation over 
time, and/or biologic loss of fixation caused by particle-induced osteolysis around the 
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implant [20]. By improving the direct structural and functional connection between living 
bone and the implant surface, or osseointegration, the life of the implant may be 
significantly increased reducing the need for revision surgery.  
 
Figure 1.1 Titanium is commonly used for the acetabular shell and/or the femoral stem in hip implants and 
the stemmed tibial plate in knee implants. Components of (a) hip (Reprinted from [21], Copyright (2018) 
Stryker Corp.) and (b) knee implants (Adapted from www.hss.edu/conditions_understanding-implants-in-
knee-and-hip-replacement.asp [22]).  
  
1.3 Implant Surface Modifications 
Studies have shown that cell adhesion, proliferation, and differentiation on an 
implant can be manipulated by altering the surface of the implant. Adding a surface 
coating to Ti is one approach to altering cell response on the surface. Studies have 
explored Ti surfaces with hydroxyapatite [23,24], calcium phosphate [25–28], and other 
cell enhancing biomolecules [29] to encourage cells to adhere and proliferate on the 
surface. Research studies have shown that these types of coatings enhance the cells 
response to the surface in vitro [23,24] and improve bone formation around the implant in 
in vivo animal studies [28]. Clinical studies looking at differences between coated and 
uncoated implants in human total hip replacement disagree on whether the coating 




with the coating while others show no benefit [30]. There is also controversy on the effects 
of bioresorption, or degradation, of hydroxyapatite and other coatings when implanted in 
the body [30]. Today hydroxyapatite is a common coating that can be added to some 
components of hip and knee implants (Figure 1.2).  
 
Figure 1.2 Examples of hydroxyapatite coatings on current hip and knee implants. (a) Hydroxyapatite 
coating on acetabular shell for him implant (Reprinted from [21], Copyright (2018) Stryker Corp.) (b) Tibial 
base plate with hydroxyapatite coated beads for knee implant (Adapted from rcmclinic.com/patient-
information/knee-information/athletic-knee-implant-overview/athletic-knee-implant-technology-v2  [31]) 
 
Altering the topography of the surface is another approach to enhancing cell 
response to encourage bone formation on the implant. Some examples of microscale 
topographical modifications are micromachining [32], sanding/grit blasting [33–35] 
plasma spraying [16,36], and acid etching [37] to name a few (Figure 1.3). Today plasma 
spraying is the technique most commonly used to micro-structure the surface of titanium 
components in both hip and knee implants. Some companies offer an additional coating 





Figure 1.3 Examples of micro-scale topographies on titanium implant surfaces. (a) Micromachining on 
titanium screw (Reprinted from [39], Copyright (2018) Micropat) (b) Titanium surface structure after 
sandblasting with aluminum oxide grit (Reprinted from [40], Copyright (2018) 101Bios) (c)  Titanium plasma 
spray coating on hip stem implant (Reprinted from [41], Copyright (2018) Medacta) (b) Surface structure 
after acid etching on titanium screw (Reprinted from [40], Copyright (2018) 101Bios) 
 
the implant. Micro-coated and micro-structured joint implants have now been in 
continuous clinical use for thirty years to improve osseointegration of the implant. All 
though these implants are better they still experience a degree of failure [4,38] and the 
revision rate for knee and hip joints has not significantly decreased since these micro 
surfaces were introduced [5]. Because bone has a structure that has micro and nano 
components, implants surfaces that better mimic this structural hierarchy of bone may be 






1.4 Structure of Bone  
In the human body, bone is found either in a porous trabecular framework or a 
dense cortical structure.  Bone has a hierarchical organization over length scales that 
span several orders of magnitude from the macro-scale to the nano-scale (Figure 1.4). 
 
 
Figure 1.4 Example of the hierarchical structure of bone. (a) At the macrostructure level, bone consists of 
a dense shell of cortical bone with porous cancellous bone at both ends. (b) At the microstructure level, 
bone consists of repeating osteon units within the cortical bone. (c) At the nanostructure level, bone consists 
of collagen fibers (100–2,000 nm) that are composed of collagen fibrils (10’s nm). (Reprinted from [42], 
Copyright (2015) Bone Research)  
 
The macrostructure level of bone consists of a dense shell of cortical bone with porous 
cancellous bone at both ends. Within the cortical bone there are repeating osteon units 
(170–250 μm diameter) which are the units of bone produced during remodeling. 
Osteons are composed of 20–30 concentric layers of collagen fibers, called lamellae (2–
9 μm thickness). These lamellae all surround a central vascular canal called the 
Haversian canal (60–90 μm diameter) where blood vessels and nerves reside.  Collagen 
fibers (100–2,000 nm) that make up the lamellae are composed of collagen fibrils (80–
100 nm diameter) [42]. Within the fibrils, type I collagen molecules (1.5 nm diameter, 
300 nm length) and hydroxyapatite nanocrystals form a composite structure [43].  
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1.5 Nano Structured Ti Surfaces 
Since bone tissue is composed of various components that are nanoscale [44], a 
surface that mimics this structural hierarchy and provides cues at the nanoscale may 
further improve the response of cells on the surface to enhance bone formation and 
improve long term stability of the implant [45,46]. Thus far, nanosurfaces have not been 
implemented for joint implants, however, many studies are currently directed towards 
understanding how nanoscale topographies on Ti surfaces can improve implant 
integration. Some nano-topographies that have been explored in research are nanofibers 
[47,48], nanopores [49–52], nanotubes (NT) [51,53–58], and other nanosurfaces [15,35] 
(Figure 1.5). Studies have shown that a Ti surface with a nanotopography not only 
promotes cell adhesion and proliferation of cells [47,59–61], it also supports differentiation 
of stem cells along the osteogenic line [49,62–64].  It can be hypothesized that a 
nanotopography on a Ti surface replicates the porous structure of native bone and 
creates an ideal environment for osteogenesis. 
Previous studies have shown that titania NT, fabricated on the surface of titanium 
using an anodization technique, provide a template with a hierarchy similar to that of 
natural tissue [51,56,62,65–67] and have been shown to alter cellular functionality on the 
surface similar to that of natural tissue [51,68]. Additionally, titanium implants with a NT 
surface topography have been shown to improve fixation of solid implants to the 
surrounding bone tissues in in vivo animal studies [69,70]. However the optimal size of  
nanosurfaces to promote cell adhesion, proliferation, and differentiation is still disputed 
[53,54,60,64,71,72]. Because stem cells are important in the healing process, it is 
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essential to study the response of stem cells on these nanostructured surfaces in vitro 
and in vivo. 
 
Figure 1.5 Examples of and nano-scale topographies on Ti surfaces.  (a)  Titanium nanofibers (Reprinted 
from [47], Copyright (2014) Int. J. Nanomedicine) (b) Titanium nanofibers with stem cells (Reprinted from 
[47], Copyright (2014) Int. J. Nanomedicine) (c) Titanium nanopores (Reprinted from [49], Copyright (2016) 
Int. J. Nanomedicine) (d) Titanium nanopores with stem cells (Reprinted from [49], Copyright (2016) Int. J. 
Nanomedicine) (e) Titania nanotubes (f) Titania nanotubes with stem cells 
  
1.6 Adipose-derived Stem Cells 
Stem cells are unspecialized cells capable of renewing themselves through self-
renewal and can be induced to become specialized cells within specific tissue by 
providing specific cues. In all tissues of the body, stem cells become activated when an 
injury occurs and are recruited to the injury site to aid in the tissue repair process [73]. 
b
a






When a biomaterial is implanted, the body reacts similar to an injury and stem cells are 
recruited to the implant site.  Since, stem cells play an important role in tissue repair in 
the body, their interaction with biomaterials is critical for long term success of medical 
devices. Bone marrow-derived mesenchymal stem cells (BMSC) are obtained from bone 
marrow and can be induced to differentiate into multiple cell lineages (Figure 1.6) [74].  
  
Figure 1.6 Potential cell lineages for mesenchymal stem cells (Reprinted from [81] Copyright (2014), Stem 
Cells in Aesthetic Procedures: Art, Science, and Clinical Techniques).  
 
Because bone marrow-derived mesenchymal stem cells differentiate into 
osteoblasts, bone forming cells, they are commonly used in orthopedic biomaterial 
studies. However, obtaining these stem cells from bone marrow is an invasive procedure 
and the yield rate of cells is often low [75].  An alternative to BMSC are adipose-derived 
stem cells (ADSC) which are mesenchymal stem cells obtained from adipose tissue and 
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have been identified as a putative population of multipotent stem cells since 2001 (Figure 
1.7) [76]. ADSC are easily accessible, available in large numbers, and attach and 
proliferate rapidly in culture, making them an attractive source for studies that aim to 
evaluate stem cell interaction with biomaterials [77,78]. Additionally, studies have 
demonstrated that ADSC  possess an in vitro bone formation capacity similar to that of 
bone marrow-derived mesenchymal stem cells [79,80].   
 
Figure 1.7 Adipose-derived stem cells are present in fat tissue and are easily removed (Reprinted from 
[82], Copyright (2017)  Journal of Limb Lengthening and Reconstruction). 
 
To date, very few studies have investigated the adhesion, proliferation, and 
differentiation of ADSC on titania NT surfaces. ADSC are easily proliferated in culture and 
on titanium surfaces using MEM Alpha Modification (Hyclone) media. Fluorescent 
staining of the stem cells allows visualization of ADSC distribution and the ability to 
quantify cell proliferation through nuclei counting.  ADSC display multipotency in culture 
14 
 
studies, meaning they retain the ability to differentiate into cell types of multiple different 
lineages. By providing specific cues via chemicals in the media, ADSC can be induced to 
differentiate along the adipogenic, chondrogenic, and osteogenic cell lines (Figure 1.8) 
[75,78,79]. Osteogenic differentiation is achieved by using culture medium supplemented 
with dexamethasone, β-glycerol-phosphate and ascorbate-2-phosphate [79]. After 
differentiation, osteoblast-like cells began to produce calcium phosphate within the ECM 
which can be assessed using different assay tests.  Alkaline phosphatase, type I collagen, 
osteopontin, osteocalcin, bone sialoprotein, Runx-1, BMP-2, BMP-4, parathyroid 
hormone receptor, BMP receptor 1 and 2 are all common genes that are up-regulated 
during osteogenesis process and can be investigated to confirm differentiation of the 
ADSC [78].  
 
Figure 1.8 Adipose-derived stem cells can be induced to differentiate along the adipogenic, chondrogenic, 






1.7 Focus of Research 
Since many joint implants still experience loosening and eventual failure [13–16],  
implants with nanostructured surfaces could help improve their fixation to the surrounding 
bone tissues [44,62,68,83,84] and reduce the need for revision surgery.  In order to 
develop these nanostructured surfaces it is important to understand how stem cells 
interact in an in vitro environment before moving into in vivo studies. The focus of this 
research is to better understand the effect of nanostructure size on adhesion, 
proliferation, and differentiation of ADSC in vitro. In chapter 2, the fabrication of  titania 
nanotubes (NT) with three different diameters is discussed and they are characterized via 
scanning electron microscopy, wettability using contact angle, crystallinity using glancing 
angle X-ray diffraction, and surface chemistry using X-ray photoelectron spectroscopy.  
In chapter 3, the effect of nanotube size and cell density on the adhesion and proliferation 
of human adipose-derived stem cells (ADSC) is discussed and evaluated. In chapter 4, 
the effect of NT size on the differentiation of ADSC is discussed and evaluated. By fully 
understanding the effect of nanostructure size on the adhesion, proliferation, and 
osteogenic differentiation of stem cells, implants could be specifically designed to achieve 









[1] J.M. Ortman, V. a. Velkoff, H. Hogan, An aging nation: The older population in the 
United States, Econ. Stat. Adm. US Dep. Commer. 1964 (2014) 1–28. 
doi:10.1016/j.jaging.2004.02.002. 
[2] D. Culliford, J. Maskell, A. Judge, C. Cooper, D. Prieto-alhambra, N.K. Arden, C. 
Study, Future projections of total hip and knee arthroplasty in the UK : results from 
the UK Clinical Practice Research Datalink, Osteoarthr. Cartil. 23 (2015) 594–600. 
doi:10.1016/j.joca.2014.12.022. 
[3] J.A. Singh, D.G. Lewallen, Time Trends in the Characteristics of Patients 
Undergoing Primary Total Knee Arthroplasty, Arthritis Care Res. (Hoboken). 66 
(2014) 897–906. doi:10.1002/acr.22233. 
[4] H. Maradit Kremers, D.R. Larson, C.S. Crowson, W.K. Kremers, R.E. Washington, 
C.A. Steiner, W.A. Jiranek, D.J. Berry, Prevalence of Total Hip and Knee 
Replacement in the United States., J. Bone Joint Surg. Am. 97 (2015) 1386–97. 
doi:10.2106/JBJS.N.01141. 
[5] K.J. Berry, Daniel J., Bozic, American Joint Replacement Registry ANNUAL 
REPORT 2016, 2016. 
[6] A.M. Elbuluk, A.B. Old, J.A. Bosco, R. Schwarzkopf, R. Iorio, Strategies for 
reducing implant costs in the revision total knee arthroplasty episode of care, 
Arthroplast. Today. 3 (2017) 286–288. doi:10.1016/j.artd.2017.03.004. 
[7] M. Long, H.J. Rack, Titanium alloys in total joint replacement--a materials science 
perspective., Biomaterials. 19 (1998) 1621–1639. doi:10.1016/S0142-
9612(97)00146-4. 
[8] D.F. Williams, On the mechanisms of biocompatibility, Biomaterials. 29 (2008) 
2941–2953. doi:10.1016/j.biomaterials.2008.04.023. 
[9] Y. Li, C. Yang, H. Zhao, S. Qu, X. Li, Y. Li, New developments of ti-based alloys for 
biomedical applications, Materials (Basel). 7 (2014) 1709–1800. 
doi:10.3390/ma7031709. 
[10] F. Barrère, T.A. Mahmood, K. de Groot, C.A. van Blitterswijk, Advanced 
biomaterials for skeletal tissue regeneration: Instructive and smart functions, Mater. 
Sci. Eng. R Reports. 59 (2008) 38–71. doi:10.1016/j.mser.2007.12.001. 
[11] E. Sáenz de Viteri, Virginia and Fuentes, Titanium and Titanium Alloys as 
Biomaterials, in: Tribol. - Fundam. Adv., 2013: pp. 155–181. 
17 
 
[12] F. Mahyudin, L. Widhiyanto, H. Hermawan, Biomaterials in orthopaedics, Adv. 
Struct. Mater. 58 (2016) 161–181. doi:10.1007/978-3-319-14845-8_7. 
[13] J.M. Banovetz, R. Sharp, R. a Probe, J.O. Anglen, Titanium plate fixation: a review 
of implant failures., J. Orthop. Trauma. 10 (1996) 389–94. 
http://www.ncbi.nlm.nih.gov/pubmed/8854316. 
[14] J.P. Berthet, A. Gomez Caro, L. Solovei, M. Gilbert, S. Bommart, P. Gaudard, L. 
Canaud, P. Alric, C.H. Marty-Ane, Titanium Implant Failure After Chest Wall 
Osteosynthesis, Ann Thorac Surg. 99 (2015) 1945–1952. 
doi:10.1016/j.athoracsur.2015.02.040. 
[15] M. Geetha, A.K. Singh, R. Asokamani, A.K. Gogia, Ti based biomaterials, the 
ultimate choice for orthopaedic implants - A review, Prog. Mater. Sci. 54 (2009) 
397–425. doi:10.1016/j.pmatsci.2008.06.004. 
[16] M. Yaszemski, D.J. Trantolo, Corrosion and Biocompatibility of Orthopedic 
Implants, 2004. 
[17] T. Camus, W.J. Long, Total knee arthroplasty in young patients: Factors predictive 
of aseptic failure in the 2nd–4th decade, J. Orthop. 15 (2018) 28–31. 
doi:10.1016/j.jor.2017.11.004. 
[18] D. Apostu, O. Lucaciu, C. Berce, D. Lucaciu, D. Cosma, Current methods of 
preventing aseptic loosening and improving osseointegration of titanium implants 
in cementless total hip arthroplasty: a review, J. Int. Med. Res. 0 (2017) 
30006051773269. doi:10.1177/0300060517732697. 
[19] M. Fernandez-Sampedro, C. Salas-Venero, C. Fariñas-Álvarez, M. Sumillera, L. 
Pérez-Carro, M. Fakkas-Fernandez, J. Gómez-Román, L. Martínez-Martínez, 
M.C.M. Fariñas, 26Postoperative diagnosis and outcome in patients with revision 
arthroplasty for aseptic loosening, BMC Infect. Dis. 15 (2015) 1–7. 
doi:10.1186/s12879-015-0976-y. 
[20] Y. Abu-Amer, I. Darwech, J.C. Clohisy, Aseptic loosening of total joint 
replacements: Mechanisms underlying osteolysis and potential therapies, Arthritis 
Res. Ther. 9 (2007) 1–7. doi:10.1186/ar2170. 
[21] Stryker, Hip Implant, (n.d.). www.stryker.com/us/en/portfolios/orthopaedics/joint-
replacement/hip.html%0A (accessed July 2, 2018). 
[22] D.E. Padgett, R.E. Windsor, Knee Implant, (2013). 
www.hss.edu/conditions_understanding-implants-in-knee-and-hip-
replacement.asp (accessed July 2, 2018). 
[23] C. Knabe, C.R. Howlett, F. Klar, H. Zreiqat, The effect of different titanium and 
hydroxyapatite-coated dental implant surfaces on phenotypic expression of human 




[24] R. Bosco, M. Iafisco, A. Tampieri, J.A. Jansen, S.C.G. Leeuwenburgh, J.J.J.P. Van 
Den Beucken, Hydroxyapatite nanocrystals functionalized with alendronate as 
bioactive components for bone implant coatings to decrease osteoclastic activity, 
Appl. Surf. Sci. 328 (2015) 516–524. doi:10.1016/j.apsusc.2014.12.072. 
[25] H.S. Alghamdi, R. Bosco, J.J.J.P. van den Beucken, X.F. Walboomers, J.A. 
Jansen, Osteogenicity of titanium implants coated with calcium phosphate or 
collagen type-I in osteoporotic rats, Biomaterials. 34 (2013) 3747–3757. 
doi:10.1016/j.biomaterials.2013.02.033. 
[26] H.S. Alghamdi, R. Bosco, S.K. Both, M. Iafisco, S.C.G. Leeuwenburgh, J.A. 
Jansen, J.J.J.P. Van den Beucken, Synergistic effects of bisphosphonate and 
calcium phosphate nanoparticles on peri-implant bone responses in osteoporotic 
rats, Biomaterials. 35 (2014) 5482–5490. doi:10.1016/j.biomaterials.2014.03.069. 
[27] A.A. Campbell, Bioceramics for implant coatings, Mater. Today. 6 (2003) 26–30. 
doi:10.1016/S1369-7021(03)01128-3. 
[28] E. Schiegnitz, V. Palarie, V. Nacu, B. Al-Nawas, P.W. Kämmerer, Vertical 
osteoconductive characteristics of titanium implants with calcium-phosphate-
coated surfaces - a pilot study in rabbits, Clin. Implant Dent. Relat. Res. 16 (2014) 
194–201. doi:10.1111/j.1708-8208.2012.00469.x. 
[29] H. Kokkonen, H. Niiranen, H.A. Schols, M. Morra, F. Stenbäck, J. Tuukkanen, 
Pectin-coated titanium implants are well-tolerated in vivo, J. Biomed. Mater. Res. - 
Part A. 93 (2010) 1404–1409. doi:10.1002/jbm.a.32649. 
[30] Stuart B. Goodman, Zhenyu Yao, Michael Keeney,Fan Yang, The Future of 
Biologic Coatings for Orthopaedic Implants, Biomaterials. 34 (2013) 3174–3183. 
doi:10.1016/j.biomaterials.2013.01.074. 
[31] M. Roosenberg, Cooley, Stryker Triathlon tibial base plate with hydroxyapatite 
coated beads as porous coat, (n.d.). rcmclinic.com/patient-information/knee-
information/athletic-knee-implant-overview/athletic-knee-implant-technology-v2/ 
(accessed August 2, 2018). 
[32] C. Prakash, M.S. Uddin, Surface modification of β-phase Ti implant by 
hydroaxyapatite mixed electric discharge machining to enhance the corrosion 
resistance and in-vitro bioactivity, Surf. Coatings Technol. 326 (2017) 134–145. 
doi:10.1016/j.surfcoat.2017.07.040. 
[33] C. Aparicio, A. Padrós, F.J. Gil, In vivo evaluation of micro-rough and bioactive 
titanium dental implants using histometry and pull-out tests, J. Mech. Behav. 
Biomed. Mater. 4 (2011) 1672–1682. doi:10.1016/j.jmbbm.2011.05.005. 
[34] Z. Schwartz, P. Raz, G. Zhao, Y. Barak, M. Tauber, H. Yao, B.D. Boyan, Effect of 
19 
 
Micrometer-Scale Roughness of the Surface of Ti6Al4V Pedicle Screws in Vitro and 
in Vivo, J. Bone Jt. Surgery-American Vol. 90 (2008) 2485–2498. 
doi:10.2106/JBJS.G.00499. 
[35] A. Jemat, M.J. Ghazali, M. Razali, Y. Otsuka, Surface modifications and their 
effects on titanium dental implants, Biomed Res. Int. 2015 (2015). 
doi:10.1155/2015/791725. 
[36] C.A. Simmons, N. Valiquette, R. Pilliar, Osseointegration of sintered porous-
surfaced and plasma spray-coated implants: an animal model study of early 
postimplanation healing response and mechanical stability, J. Biomed. Mater. Res. 
47 (1999) 127–138. 
[37] S. Ban, Y. Iwaya, H. Kono, H. Sato, Surface modification of titanium by etching in 
concentrated sulfuric acid, Dent. Mater. 22 (2006) 1115–1120. 
doi:10.1016/j.dental.2005.09.007. 
[38] W.T. Long, M. Dastane, M.J. Harris, Z. Wan, L.D. Dorr, Failure of the durom 
metasul® acetabular component, Clin. Orthop. Relat. Res. 468 (2010) 400–405. 
doi:10.1007/s11999-009-1071-8. 
[39] Micropat, Composite image showing the patterned implant, 2018. (n.d.). 
micropat.ch/application/prototypes-for-the-functional-micropatterning-of-a-
titanium-dental-implant/ (accessed July 2, 2018). 
[40] 101 Bios, Titanium Surface Structure after Sandblasting with Aluminum Oxide Grit 
and Acid Etching, (n.d.). http://101bios.com/blasting-etching.html (accessed 
August 2, 2017). 
[41] Medacta, Titanium plasma spray coating on hip implant stem, (n.d.). 
www.medacta.com/EN/masterloc (accessed August 2, 2018). 
[42] T. Gong, J. Xie, J. Liao, T. Zhang, S. Lin, Y. Lin, Nanomaterials and bone 
regeneration, Bone Res. 3 (2015). doi:10.1038/boneres.2015.29. 
[43] E.A. Zimmermann, E. Schaible, B. Gludovatz, F.N. Schmidt, C. Riedel, M. Krause, 
E. Vettorazzi, C. Acevedo, M. Hahn, K. Puschel, S. Tang, M. Amling, R.O. Ritchie, 
B. Busse, Intrinsic mechanical behavior of femoral cortical bone in young, 
osteoporotic and bisphosphonate-treated individuals in low-and high energy 
fracture conditions, Sci. Rep. 6 (2016) 1–12. doi:10.1038/srep21072. 
[44] M.M. Stevens, Biomaterials for bone tissue engineering, Mater. Today. 11 (2008) 
18–25. doi:10.1016/S1369-7021(08)70086-5. 
[45] G. Mendonça, D.B.S. Mendonça, F.J.L. Aragão, L.F. Cooper, Advancing dental 
implant surface technology - From micron- to nanotopography, Biomaterials. 29 
(2008) 3822–3835. doi:10.1016/j.biomaterials.2008.05.012. 
20 
 
[46] M. Kulkarni, A. Mazare, P. Schmuki, A. Iglič, Biomaterial surface modification of 
titanium and titanium alloys for medical applications, Nanomedicine. (2014) 111–
136. 
[47] A.W. Tan, L. Tay, Proliferation and stemness preservation of human adipose-
derived stem cells by surface-modified in situ TiO 2 nanofibrous surfaces, Int. J. 
Nanomedicine. 9 (2014) 5389–5401. doi:10.2147/IJN.S72659. 
[48] X. Wang, J. Zhu, L. Yin, S. Liu, X. Zhang, Y. Ao, H. Chen, Fabrication of electrospun 
silica-titania nanofibers with different silica content and evaluation of the 
morphology and osteoinductive properties, J. Biomed. Mater. Res. - Part A. 100 A 
(2012) 3511–3517. doi:10.1002/jbm.a.34293. 
[49] K. Malec, J. Goralska, M. Hubalewska-Mazgaj, P. Glowacz, M. Jarosz, P. Brzewski, 
G. Sulka, M. Jaskula, I. Wybranska, Effects of nanoporous anodic titanium oxide 
on human adipose derived stem cells, Int. J. Nanomedicine. Volume 11 (2016) 
5349–5360. doi:10.2147/IJN.S116263. 
[50] D. Yu, Y. Song, X. Zhu, R. Yang, A. Han, Morphological evolution of TiO2 nanotube 
arrays with lotus-root-shaped nanostructure, Appl. Surf. Sci. 276 (2013) 711–716. 
doi:10.1016/j.apsusc.2013.03.158. 
[51] Y. Wang, C. Wen, P. Hodgson, Y. Li, Biocompatibility of TiO2 nanotubes with 
different topographies, J. Biomed. Mater. Res. - Part A. 102 (2014) 743–751. 
doi:10.1002/jbm.a.34738. 
[52] L. Salou, A. Hoornaert, G. Louarn, P. Layrolle, Enhanced osseointegration of 
titanium implants with nanostructured surfaces: An experimental study in rabbits, 
Acta Biomater. 11 (2015) 494–502. doi:10.1016/j.actbio.2014.10.017. 
[53] M. Kulkarni, A. Flašker, M. Lokar, K. Mrak-Poljšak, A. Mazare, A. Artenjak, S. 
Čučnik, S. Kralj, A. Velikonja, P. Schmuki, V. Kralj-Iglič, S. Sodin-Semrl, A. Iglič, 
Binding of plasma proteins to titanium dioxide nanotubes with different diameters, 
Int. J. Nanomedicine. 10 (2015) 1359–1373. doi:10.2147/IJN.S77492. 
[54] L. Lv, Y. Liu, P. Zhang, X. Zhang, J. Liu, T. Chen, P. Su, H. Li, Y. Zhou, The 
nanoscale geometry of TiO2 nanotubes influences the osteogenic differentiation of 
human adipose-derived stem cells by modulating H3K4 trimethylation, 
Biomaterials. 39 (2015) 193–205. doi:10.1016/j.biomaterials.2014.11.002. 
[55] K.C. Popat, M. Eltgroth, T.J. LaTempa, C. a. Grimes, T. a. Desai, Decreased 
Staphylococcus epidermis adhesion and increased osteoblast functionality on 
antibiotic-loaded titania nanotubes, Biomaterials. 28 (2007) 4880–4888. 
doi:10.1016/j.biomaterials.2007.07.037. 
[56] S.J. Seunghan Oh, Chiara Daraio, Li-Han Chen, Thomas R. Pisanic, Rita R. Fin 
˜ones, Significantly accelerated osteoblast cell growth on aligned TiO2 nanotubes, 
J Biomed Mater Res A. 78 (2006) 97–103. doi:10.1002/jbm.a. 
21 
 
[57] S.-H. An, R. Narayanan, T. Matsumoto, H.-J. Lee, T.-Y. Kwon, K.-H. Kim, 
Crystallinity of anodic TiO2 nanotubes and bioactivity., J. Nanosci. Nanotechnol. 11 
(2011) 4910–4918. doi:10.1166/jnn.2011.4114. 
[58] R. Ge, W. Fu, H. Yang, Y. Zhang, W. Zhao, Z. Liu, C. Wang, H. Zhu, Q. Yu, G. Zou, 
Fabrication and characterization of highly-ordered titania nanotubes via 
electrochemical anodization, Mater. Lett. 62 (2008) 2688–2691. 
doi:10.1016/j.matlet.2008.01.015. 
[59] J. Park, S. Bauer, K.A. Schlegel, F.W. Neukam, K. Der Von Mark, P. Schmuki, TiO2 
nanotube surfaces: 15 nm - an optimal length scale of surface topography for cell 
adhesion and differentiation, Small. 5 (2009) 666–671. 
doi:10.1002/smll.200801476. 
[60] J. Park, S. Bauer, K. Von Der Mark, P. Schmuki, Nanosize and vitality: TiO2 
nanotube diameter directs cell fate, Nano Lett. 7 (2007) 1686–1691. 
doi:10.1021/nl070678d. 
[61] S. Bauer, J. Park, A. Pittrof, Y.-Y. Song, K. von der Mark, P. Schmuki, Covalent 
functionalization of TiO(2) nanotube arrays with EGF and BMP-2 for modified 
behavior towards mesenchymal stem cells., Integr. Biol. (Camb). 3 (2011) 927–
936. doi:10.1039/c0ib00155d. 
[62] C.J. Frandsen, K.S. Brammer, S. Jin, Variations to the nanotube surface for bone 
regeneration, Int. J. Biomater. 2013 (2013). doi:10.1155/2013/513680. 
[63] K.S. Brammer, S. Oh, J.O. Gallagher, S. Jin, Enhanced cellular mobility guided by 
TiO2 nanotube surfaces, Nano Lett. 8 (2008) 786–793. doi:10.1021/nl072572o. 
[64] S. Oh, K.S. Brammer, Y.S. Julie, D. Teng, A. Engler, S. Chien, S. Jin, Stem cell 
fate dictated soley by altered nanotube dimension, Proceeding Natl. Acad. Sci. 106 
(2009) 2130–2135. 
[65] T.A. Popat, Ketul C.; Daniels, R. Hugh; Dubrow, Robert S.; Hardev, Veeral; Desai, 
Nanostructured Surfaces for Bone Biotemplating Applications, Anticancer Res. 
(2006) 619–627. doi:10.1002/jor. 
[66]  a. W. Tan, B. Pingguan-Murphy, R. Ahmad, S. a. Akbar, Review of titania 
nanotubes: Fabrication and cellular response, Ceram. Int. 38 (2012) 4421–4435. 
doi:10.1016/j.ceramint.2012.03.002. 
[67] E. Anodization, J. Wang, Z. Lin, Freestanding TiO 2 Nanotube Arrays with Ultrahigh 
Aspect Ratio, (2008) 1257–1261. 
[68] M. Kulkarni,  a Mazare, E. Gongadze, Š. Perutkova, V. Kralj-Iglič, I. Milošev, P. 
Schmuki, A Iglič, M. Mozetič, Titanium nanostructures for biomedical applications, 
Nanotechnology. 26 (2015) 62002. doi:10.1088/0957-4484/26/6/062002. 
22 
 
[69] L.M. Bjursten, L. Rasmusson, S. Oh, G.C. Smith, K.S. Brammer, S. Jin, Titanium 
dioxide nanotubes enhance bone bonding in vivo, J. Biomed. Mater. Res. - Part A. 
92 (2010) 1218–1224. doi:10.1002/jbm.a.32463. 
[70] N. Wang, H. Li, W. Lu, J. Li, J. Wang, Z. Zhang, Y. Liu, Effects of TiO2 nanotubes 
with different diameters on gene expression and osseointegration of implants in 
minipigs, Biomaterials. 32 (2011) 6900–6911. 
doi:10.1016/j.biomaterials.2011.06.023. 
[71] M. Lai, K. Cai, L. Zhao, X. Chen, Y. Hou, Z. Yang, Surface Functionalization of TiO 
2 Nanotubes with Bone Morphogenetic Protein 2 and Its Synergistic Effect on the 
Differentiation of Mesenchymal Stem Cells, (2011) 1097–1105. 
[72] R. Zhang, H. Wu, J. Ni, C. Zhao, Y. Chen, C. Zheng, X. Zhang, Guided proliferation 
and bone-forming functionality on highly ordered large diameter TiO<inf>2</inf> 
nanotube arrays, Mater. Sci. Eng. C. 53 (2015). doi:10.1016/j.msec.2015.04.046. 
[73] K.P. Krafts, The hidden drama Tissue repair, Organogenesis. 6 (2010) 225–233. 
doi:10.4161/org6.4.12555. 
[74] D.C. Colter, R. Class, C.M. DiGirolamo, D.J. Prockop, Rapid expansion of recycling 
stem cells in cultures of plastic-adherent cells from human bone marrow, Proc. Natl. 
Acad. Sci. 97 (2000) 3213–3218. doi:10.1073/pnas.97.7.3213. 
[75] B. Lindroos, R. Suuronen, S. Miettinen, The Potential of Adipose Stem Cells in 
Regenerative Medicine, Stem Cell Rev. Reports. 7 (2011) 269–291. 
doi:10.1007/s12015-010-9193-7. 
[76] P. Zuk, Adipose-Derived Stem Cells in Tissue Regeneration: A Review, Int. Sch. 
Res. Not. 2013 (2013) e713959. doi:10.1155/2013/713959. 
[77] A.S. Zanetti, C. Sabliov, J.M. Gimble, D.J. Hayes, Human adipose-derived stem 
cells and three-dimensional scaffold constructs: A review of the biomaterials and 
models currently used for bone regeneration, J. Biomed. Mater. Res. - Part B Appl. 
Biomater. 101 B (2013) 187–199. doi:10.1002/jbm.b.32817. 
[78] W. Tsuji, Adipose-derived stem cells: Implications in tissue regeneration, World J. 
Stem Cells. 6 (2014) 312. doi:10.4252/wjsc.v6.i3.312. 
[79] B.A. Bunnell, M. Flaat, C. Gagliardi, B. Patel, C. Ripoll, Adipose-derived stem cells: 
Isolation, expansion and differentiation, Methods. 45 (2008) 115–120. 
doi:10.1016/j.ymeth.2008.03.006. 
[80] Y.C. Halvorsen, D. Franklin, A.L. Bond, D.C. Hitt, C. Auchter, A.L. Boskey, D. Ph, 
E.P. Paschalis, Extracellular Matrix Mineralization and Osteoblast, Tissue Eng. 7 
(2001) 729–41. 
[81] E. Bolletta, E. Petrucci, C. Tartaglione, D. Bordoni, Adipose-Derived Stem Cells 
23 
 
(ADSCs): Current Findings and Future Perspectives in Structural Facial Fat 
Grafting, in: M.A. Shiffman, A. Di Giuseppe, F. Bassetto (Eds.), Stem Cells 
Aesthetic Proced. Art, Sci. Clin. Tech., Springer Berlin Heidelberg, Berlin, 
Heidelberg, 2014: pp. 383–414. doi:10.1007/978-3-642-45207-9_26. 
[82] R.H. Yasir Alabdulkarim, Bayan Ghalimah, Mohammad Al-Otaibi1, Hadil F Al-
Jallad, Mina Mekhael, Bettina Willie5, Recent advances in bone regeneration: The 
role of adipose tissue-derived stromal vascular fraction and mesenchymal stem 
cells, J. Limb Lengthening Reconstr. 3 (2017) 4–18. 
[83] D.L.C. Barbara D Boyan, ChristophHLohmann, David D Dean, VictorLSylvia,  and 
Z. Schwartz, Mechanisms Involved in Osteoblast Response to Implant Surface 
Morphology, Annu. Rev. Mater. Res. 31 (2001) 357–371. 
[84] H.-I. Chang, Y. Wang, Cell Responses to Surface and Architecture of Tissue 




CHAPTER 2  




Titania nanostructured surfaces were first discovered in the late 1990s.  There are 
the three main methods to synthesize various nanostructured forms of titania; template-
assisted, electrochemical, and hydrothermal [1]. Electrochemical anodization is a cost-
effective and simple method to prepare titania nanotubes (NT).  The anodization is 
performed in a two electrode system with a titanium anode and a platinum cathode 
immersed in a fluoride-ion containing electrolyte solution. The NT are formed by selective 
etching, followed by a chemical dissolution that results in the nucleation of nanopores on 
the surface [1]. Continuing the anodization process leads to a steady-state growth on the 
metal surface resulting in tubular geometries [1]. Over the last two decades, this synthesis 
process has improved through the discovery that altering the pH value of the electrolyte 
can improve the tube layer thickness and that a neutral pH value produces longer tubes 
[2]. Additionally, it was demonstrated that non-aqueous electrolytes produce smooth 
tubes  with uniform ordering of the nanotubes [2]. Today there are many different 
electrolyte compositions being used to fabricate titania nanotubes and each result in a 
unique nanotube structure and ordering. Changing other parameters such as time, 
temperature, and voltage during anodization also alter nanotube size and structure.   
This chapter addresses specific aim 1. In this chapter titania nanotubes (NT) were 
prepared on titanium surfaces by anodization using an organic electrolyte solution. The 
NT surfaces were made at three different diameters by altering the voltage and duration 
of the anodization process. Since these NT surfaces are being explored as a biomaterial 
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it is important to define their surface characteristics and therefore analyze their potential 
to support cellular activity. Cells interaction with a surface is driven by the proteins 
adhered on the surface [3,4]. There are several material factors that can affect how 
proteins adhere and interact with a biomaterial surface including, but not limited to, 
surface chemistry, surface wettability, surface roughness, crystallinity and size of the 
topography. Thus it is important to evaluate these material characteristics of the NT 
surface in order to determine the potential of NT as an implant surface before proceeding 
to in vitro cell studies.  In this chapter, tube size, surface wettability, crystalline structure, 
and surface chemistry are evaluated and discussed for all three NT surfaces. 
 
2.1 Methods and Materials 
2.1.1 Fabrication of Nanotube Surfaces 
Titania nanotubes (NT) surfaces were fabricated using electrochemical 
anodization. Titanium foil surfaces, 0.635 mm thick (CP Grade 1 Titanium), were cleaned 
with acetone, soap, and isopropanol before anodization. An electrochemical cell was 
developed with the titanium surfaces acting as the anode, and platinum foil acting as the 
cathode.  The electrolyte solution was prepared by mixing diethylene glycol (DEG, 99% 
v/v) with 2% hydrofluoric acid (HF, 48% v/v) and 3% de-ionized water (Figure 2.1). NT 
with 65 nm diameter were obtained by anodizing at 30 V for 46 hours, 100 nm diameters 
at 45 V for 24 hours, and 160 nm diameters at 60 V for 24 hours. When anodization time 




then dried with nitrogen gas. The surfaces were then annealed at 530°C for 3 hours. NT 
surfaces are denoted NT30, NT45, and NT60 and the titanium control surface is denoted 
Ti.
 
Figure 2.1 Schematic of anodization setup for fabrication of titania nanotube surfaces (Reprinted from [5], 
Copyright (2012) Smith, B.). 
 
2.1.2 Characterization of Nanotube Surfaces 
In order to characterize nanotube morphology, scanning electron microscopy 
(SEM, JEOL JSM-6500F) was employed at an accelerating voltage of 15kV. Images were 
taken at 2,500, 10,000, and 50,000 magnification on two different locations on each 
sample.   
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Material surface wettability was evaluated by using a water-drop method on a 
contact angle goniometer (ramé-hart 250). A predetermined volume of water was dropped 
onto the NT surfaces and images of the water droplet were immediately captured. The 
images were analyzed to determine the contact angles using DROPimage software.  
Chemical composition on the NT and Ti surfaces was characterized by X-ray 
photoelectron spectroscopy (XPS, ESCA Systems X-ray Photoelectron Spectrometer 
5800). XPS is a surface sensitive technique that detects trace levels of elements present 
on the surface. Ten minute survey spectra were collected from 0 to 1100eV with a pass 
energy of 187.85 eV using the binding energy of carbon (C1s: 284.8 eV) as the reference. 
Data for percent elemental composition, elemental ratios and peak fit analysis were 
calculated using Multipack software. 
In order to determine the crystalline phases present on the NT surfaces, glancing 
angle X-ray diffraction (GAXRD) was performed with a Bruker D-8 Discover X-ray 
diffraction system with a Cu X-ray source and line focus optics on NT and Ti surfaces. A 
scintillation detector and soller slits (~0.4  separation) were used on the diffracted beam 
side to record the XRD spectra. GAXRD measurements were performed with a fixed 
angle of incidence of 1.50  to maximize the signal from the films and a detector scan was 
carried out to record the diffracted X-ray intensity as a function of 2 .  
 
2.1.3 Statistical analysis  
All studies were performed with nmin = 3 for qualitative analyses and nmin = 5 for 
quantitative analyses. The statistical differences were compared using one-way ANOVA 
analysis (p < 0.05) with a post-hoc Tukey's HSD (honest significant difference) test.  
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Minitab software was used to conduct the statistical analysis. All data is shown as the 
average ± standard errors. 
 
2.2 Results and Discussion 
Different nanotube surfaces were fabricated using anodization at 30 V (NT30), 45 V 
(NT45), and 60 V (NT60). Scanning electron microscopy (SEM, JEOL JSM-6500F) was 
used at an accelerating voltage of 15kV to characterize NT morphology, inner diameter, 
and NT length (Figure 2.2). The titanium control (Ti) surface exhibited a smooth surface 
with visible grain boundaries and no unique features.  The NT surfaces were uniform with 
NT attached at the base and formed perpendicular to the surface with occasional broken 
NT observed on the surfaces. 
SEM images also confirmed that as the anodization voltage increased, the 
diameter of the NT increased resulting in average diameters of 65 ± 15 nm for 30 V, 95 ± 
25 nm for 45 V, and 160 ± 30 nm for 60V (Figure 2.3).  SEM images of NT cross-sectional 
lengths were obtained by fracturing the NT surfaces before imaging.  The cross sectional 
tube lengths were 0.7 ± 0.1 µm for 30 V, 2.1 ± 0.2 µm for 45 V, and 3.3 ± 0.8 µm for 60 
V.  The inner diameter and tube length were assessed using ImageJ software with SEM 
images. Voltage, time, composition of electrolyte solution, and temperature of the 
electrolyte solution during anodization all influence NT formation [6,7]. Studies have 
shown that NT diameter and length have an almost linear relationship to the applied 




Figure 2.2 SEM images of Titanium (Ti) and nanotubes made at 30 V (NT30), 45 V (NT45), and 60 V (NT60) at (A) 10,000 and (B) 50,000 















In this study, the tube length displayed a nearly linear relationship with the anodization 
voltage, while, inner diameter was not linear, but still increased as voltage increased 
(Figure 2.3).  
 
Figure 2.3 Average inner diameter and cross sectional length of nanotubes made at 30 V (NT30), 45 V 
(NT45), and 60 V (NT60).  All NT inner diameter and tube length are significantly different. (*Tukey’s HSD 
p<0.05) Full statistical analysis found in Appendix I. 
 
Wettability plays an important role in cell-surface interaction as the wetting 
characteristic affects the protein adsorption and the proteins direct cell adhesion and 
proliferation [9,10].  A wettable surface is termed hydrophilic and a non-wettable surface 
hydrophobic. A surface with a contact angl e lower than 90° is considered hydrophilic and 
a contact angle higher than 90° is considered hydrophobic. Earlier studies have shown 
that hydrophilic surfaces not only enhance cell adhesion and proliferation [3] but improve 
the initial blood contact, accelerating implant osseointegration [11]. In this study wettability 




























































results indicate that the Ti surface was hydrophilic at 57°, however, the NT surfaces 
displayed improved hydrophilic properties with contact angles <10° (Figure 2.4).  
 
Figure 2.4 Water contact angle on Ti and NT surfaces with representative images. Ti control surface is 
significantly different from NT30, NT45, and NT60 indicating that nanotubes are more hydrophilic than 
Titanium. (*Tukey’s HSD p<0.05) Full statistical analysis found in Appendix I. 
 
The crystallinity of a surface is also important as cells respond differently to 
different crystal structures. Nanotubes are primarily titanium dioxide (TiO2) also known as 
titania.  Titania can exist as an amorphous layer or in crystalline phases: anatase 
(tetragonal), rutile (tetragonal) and brookite (orthorhombic). Only rutile phase is 
thermodynamically stable at high temperatures. Titania nanotubes are amorphous right 
after the anodization process however annealing the samples at a high temperature 




























structure appear vary based on the anodization parameters and chemicals present on the 
NT surface [2]. Typically, titania nanotubes annealed above 250oC will exhibit an anatase 
crystalline structure. At temperatures near or above 430ºC-500 ºC a rutile crystalline 
structure is present along with the anatase [12]. Above 680ºC degrees the crystalline 
structure becomes completely rutile [13,14]. The crystallinity of the Ti and NT surfaces 
was determined using glancing angle X-ray diffraction (GAXRD). All the NT surfaces 
exhibited anatase ( ) and rutile ( ) phases (Figure 2.5).  NT60 exhibited a higher 
anatase phase and smaller rutile phase than the NT30 and NT45 (at 25  and 27 ) 
indicating that the content of anatase phase decreases and the content of rutile increases 
with decreasing anodization voltage. Decreases in the anatase peak as voltage 
decreased can also be seen at 38° and 48° for all NT surfaces. Other studies have 
reported similar findings [15,16].  Studies have shown that cells performed better on 
annealed NT (crystalline) over non-annealed (amorphous) NT surfaces [17,18] and that 
osteoblasts preferred anatase coated titanium surfaces over rutile and amorphous 
surfaces [19]. Since all NT surfaces in this study exhibit high anatase content, the 




Figure 2.5 Glancing angle X-ray diffraction (GAXRD) of Ti and NT surfaces after annealing indicating anatase and rutile crystalline phases. 
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Many studies have shown that cells respond to chemicals found on an implant 
surface, thus X-ray photoelectron spectroscopy (XPS) was performed to determine the 
chemical composition on Ti and NT surfaces before cell culture was performed.  From the 
survey scans it is clear that all surfaces contained carbon, titanium, and oxygen (Figure 
2.6). Since nanotubes are compositionally TiO2, the titanium and oxygen content is 
expected (Figure 2.7).  The high content of carbon was not expected and is probably a 
combination of environmental contamination and a carbon rich layer that forms on the 
outer part of the NT when using an organic electrolyte during anodization [20]. Carbon 
content on NT surfaces has been reported in several other NT studies as well [14,21,22]. 
All the NT surfaces exhibit fluoride on the surfaces due to the hydrofluoric (HF) acid used 
in the anodization process. At high concentrations, fluoride can be toxic to cells, but at 
low concentrations, fluoride has been shown to influence proliferation and migration of 
some cell types [23–27].  
 
 Figure 2.6 Chemical Compositions (Oxygen, Carbon, Titanium and Fluoride) of Ti and nanotube (NT) 
surfaces measured by XPS.   
O % C % Ti % F %
Ti 52.7 35.2 12.1 0.0
NT30 53.9 32.3 11.2 2.6
NT45 56.3 21.4 20.3 2.0
NT60 46.0 37.4 15.7 0.9
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Titania nanotubes (NT) with three different diameters were fabricated and inner 
diameter and length of NT were characterized via scanning electron microscopy (SEM). 
Wettability of all NT surfaces is strong and exhibited higher hydrophilicity than Ti control. 
Glancing angle X-ray diffraction (GAXRD) revealed all NT surfaces in this study exhibit 
high anatase content after annealing with some rutile content. X-ray photoelectron 
spectroscopy (XPS) indicated small percentages of fluoride present on all three NT 
surfaces. In conclusion, all of these surface characterization tests suggest that all three 
NT surfaces should be ideal for in vitro cell studies and have the potential to promote cell 
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CHAPTER 3  
EVALUATION OF THE EFFECT OF TITANIA NANOTUBES ON ADHESION AND 




The success of any clinical implant is dependent on the interaction of cells with the 
implant surface.  A successful orthopedic implant will promote cell adhesion and 
proliferation in order to stimulate osseointegration of the implant with the surrounding 
bone tissue. When a surface is initially exposed to in vitro culture conditions, proteins in 
the cell culture media adsorb to the material’s surface and mediate cell adhesion through 
signals to the cells through the cell’s adhesion receptors (integrins) and protein functional 
groups (ligands)  [1,2]. Cells then adhere on the surfaces and release active compounds 
for signaling, perform extra-cellular matrix deposition, proliferate and differentiate [1]. So 
one of the first steps in determining the potential of a new implant is to study the adhesion 
and proliferation of cells on the surface in vitro, specifically stem cells. When a biomaterial 
is implanted, the body reacts similar to an injury and stem cells are recruited to the implant 
site.  Since, stem cells play an important role in tissue repair in the body, it is essential to 
understand their interaction with the implant surface. Adipose-derived stem cells (ADSC) 
are mesenchymal stem cells obtained from adipose tissue that are easily accessible, 
available in large numbers, and attach and proliferate rapidly in culture, making them an 
attractive source for studies that aim to evaluate stem cell interaction with implant 
surfaces [3,4]. Additionally, studies have demonstrated that ADSC possess an in vitro 
bone formation capacity similar to that of bone marrow-derived mesenchymal stem cells 
[5,6].   
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This chapter addresses specific aim 2. In this chapter the culturing of adipose-
derived stem cells (ADSC) for one week on titanium (Ti) and nanotube (NT) surfaces is 
evaluated and discussed.  Not only does surface topography affect cell proliferation, but 
cell density does as well, thus, ADSC were cultured at three different cell densities to 
determine the optimal cell density for further studies. Adhesion and proliferation are 
investigated using a viability assay, fluorescent staining, and scanning electron 
microscope to visualize cell morphology. 
 
3.1 Methods and Materials 
3.1.1 Adipose-Derived Stem Cell (ADSC) Culture 
ADSC were isolated from abdominal and femoral subcutaneous adipose tissue 
biopsy surfaces as described previously [7].  When ready for culturing the ADSC were 
thawed and expanded using standard cell culture techniques. All ADSC used in this study 
were below passage five. Following expansion, ADSC were detached using 0.25% 
Trypsin and suspended in growth media (MEM Alpha Modification, HyCloneTM) with 10% 
fetal bovine serum and 1% penicillin/streptomycin added.  NT and Ti surfaces were 
sterilized by incubation in 70% ethanol at room temperature for 10 minutes and then 
rinsed twice with warm phosphate buffered saline (PBS).  Following sterilization, the 
surfaces were exposed to UV light for 30 mins.  
 
3.1.2 ADSC Adhesion and Proliferation  
ADSC were cultured on NT and Ti surfaces in 48-well plates at 500 µl per well with 
three different cell densities: 2,500, 3,750, and 5,000 cells/well.  The surfaces were 
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incubated at 37 °C and 5% CO2 for the entire duration of the study. Media changes were 
done on day 2 and 5 with prepared growth media. Fluorescent staining and proliferation 
assays were done after 1, 4, and 7 days.   
A measurement of cell viability is important in evaluating the capacity for a scaffold 
to support initial cell proliferation. Viability of ADSC was assessed using alamarBlue® 
(ThermoFisher Scientific) cell viability assay after 1, 4, and 7 days of proliferation.  
Surfaces were moved to a new well plate on day one to mitigate the effect from ADSC 
adhered in the well plate.  300 µl fresh media was added to surfaces along with 30 µl of 
alamarBlue®.  Well plates were covered with foil and incubated for 4 hours.  After 
incubation, 100 µl was removed from each well and placed in a 96 well plate.  Absorbance 
was read at 570 nm and 600 nm.  A control well with media plus alamarBlue® was used 
to determine the percent reduction of alamarBlue® for each surface.  
Fluorescent staining was used to characterize cell adhesion. Media was removed 
and the NT and Ti surfaces were washed twice with warm PBS and then moved to a new 
well plate. ADSC were stained with 5-chloromethylfluorescein diacetate (CellTracker 
green CMFDA, Invitrogen) live stain. The surfaces were incubated with 10 μM CMFDA in 
PBS for 30 min at 37 °C and 5% CO2. CMFDA was removed and ADSC were rinsed three 
times in PBS and incubated for another 30 min at 37 °C and 5% CO2. The surfaces were 
fixed in 3.7 wt % formaldehyde in PBS for 15 min at room temperature, followed by three 
washes (5 min per wash) with PBS. Adhered ADSC were permeabilized by incubation in 
1% Triton-X in PBS for 3 min and rinsed with PBS. After transferring surfaces to a new 
well plate, ADSC were incubated in 70nM of Rhodamine Phalloidin (Cytoskeleton) in PBS 
at room temperature for 25 minutes.  DAPI (ThermoFisher Scientific) nuclear stain (300 
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nM) was added for 5 min at room temperature and surfaces were rinsed twice with PBS 
and imaged with a fluorescence microscope (Zeiss). ADSC cell count was determined by 
counting the number of DAPI stained nuclei from the fluorescence images at 10x 
magnification. 
In order to examine cell morphology and cell–substrate interaction, the ADSC were 
fixed and dehydrated after 1, 4 and 7 days proliferation in growth media.  Surfaces were 
removed from media and placed in the primary fixative of 3% glutaraldehyde (Ted Pella, 
Inc.), 0.1 M of sodium cacodylate (ACROS Organics), and 0.1 M sucrose (Fisher) for 45 
minutes.  Surfaces were then moved to the buffer solution containing 0.1M sodium 
cacodylate and 0.1 M sucrose. The ADSC were then dehydrated by replacing the buffer 
with increasing concentrations of ethanol (35%, 50%, 70%, and 100%) for 10 minutes 
each. The ADSC were then dried by hexamethyldisilazane (HMDS, Aldrich) for 10 min. 
After HMDS was removed, the surfaces were air dried for 30 minutes and then placed in 
a desiccator.   The surfaces were sputter coated with 10nm of gold before imaging using 
a Scanning Electron Microscope (JEOL JSM-6500F) at an accelerating voltage of 10 kV.   
 
3.1.3 Statistical analysis  
All studies were performed with nmin = 3 for qualitative analyses and nmin = 5 for 
quantitative analyses. The statistical differences were compared using one-way ANOVA 
analysis (p < 0.05) with a post-hoc Tukey's HSD (honest significant difference) test.  
Minitab software was used to conduct the statistical analysis. All data is shown as the 




3.2 Results and Discussion 
Since titanium implants still experience loosening and eventual failure [8–11],  
implants with nanostructured surfaces could help improve their fixation to the surrounding 
bone tissues [1,12–15]. By more fully understanding the effect of nanostructure size on 
adhesion and proliferation of stem cells, implants could be specifically designed to 
achieve the optimal stem cell response from the tissue in which they are implanted. In 
this chapter, the effect of nanotube (NT) size and cell density on the adhesion and 
proliferation of human adipose-derived stem cells (ADSC) was evaluated.  
The size of the surface topography can influence cell behavior, thus, titania 
nanotube surfaces were fabricated at three different sizing using anodization at 30 V 
(NT30) 45 V (NT45) and 60 V (NT60) as described in Chapter 2. Not only does surface 
topography affect cell proliferation, but cell density does as well, thus, ADSC were 
cultured on Ti and NT surfaces for 7 days at three different cell densities: 2,500, 3,750, 
and 5,000 cells/well. It is important to evaluate the ability of a surface to support initial cell 
proliferation by measuring the cell viability.  AlamarBlue®, a commercially available 
assay, was used to investigate cell viability. AlamarBlue® is a proven cell viability 
indicator that uses the natural reducing power of living cells to convert a cell permeable 
compound (resazurin) to a fluorescent molecule (resorufin). The amount of absorbance 
is proportional to the number of living cells and corresponds to the cells metabolic activity.  
In this study, the percent reduction of alamarBlue® from a control well was calculated 
from the absorbance readings after 1, 4, and 7 days (Figure 3.1).  The percent increase 
from day 1 to day 7 was calculated in order to determine the cell density that had the 
highest increase in viability during the week (Figure 3.3). The 2,500 and 3,750 cells/well 
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densities showed similar increases across all surfaces, whereas, the 5000 cells/well 
density exhibited a much lower percent increase from day 1 to day 7 for all surfaces.  
Since these results were not conclusive as to which cell density was the best, cells were 
stained and florescent microscopy was used to count the cells and to visualize ADSC 
distribution.  
Fluorescent staining was performed after 1 and 7 days (Figures 3.4-3.6)).  From 
the fluorescent images it is clear that the ADSC proliferated on all the surfaces for all cell 
densities from day 1 to day 7. However, the cells on the Ti surfaces tended to clump 
together, whereas the cells on the NT surfaces were dispersed with space between the 
cells. Cell count was determined using ImageJ software to count the DAPI nuclei stain on 
fluorescent (10x) images from each surface (Figure 3.2). The ADSC were spread and 
elongated on the NT surfaces and their nuclei were easy to count, however, cells on Ti 
surfaces were close together making the nuclei difficult to count and produced large 
standard deviations for Ti after day 7. It is interesting to note that viability for Ti is high but 
cell count for Ti is low after 7 days. This could be due to the ADSC on the Ti weakly 




Figure 3.1 Adipose-derived stem cell viability after 1, 4 and 7 days determined by percent reduction of alamarBlue assay for (a) 2,500 cells/well, (b) 
3,750 cells/well and (c) 5,000 cells/well densities. 
 
 
Figure 3.2 Cell count of adipose-derived stem cells after 1, 4 and 7 days for Ti and NT surfaces cultured at (a) 2,500 cells/well, (b) 3,750 cells/well 




































































































































































































































Figure 3.4 Fluorescent microscopy images of adipose-derived stem cells cultured at 2,500 cells/well density on Ti and NT surfaces after day 1, 4, 
and 7 of proliferation (scale bar 100µm). 
 
 







Figure 3.5 Fluorescent microscopy images of adipose-derived stem cells cultured at 3,750 cells/well density on Ti and NT surfaces after day 1, 4, 
and 7 of proliferation (scale bar 100µm). 
 
 







Figure 3.6 Fluorescent microscopy images of adipose-derived stem cells cultured at 3,750 cells/well density on Ti and NT surfaces after day 1, 4, 
and 7 of proliferation (scale bar 100µm). 






Studies have reported that cells cultured on smooth Ti were easily removed, whereas 
cells cultured on rougher Ti surfaces require multiple treatments of trypsin and still some 
cells remain adhered to the surface [13]. Additionally on rough surfaces, cells divide 
slower, but adhere and differentiate faster [13]. 
In this study the results show that proliferation decreased as the size of NT 
increased. This decrease in proliferation may be due to the cells expending their energy 
to elongate and adhere firmly to the surface rather than proliferating. Overall, the ADSC 
count was higher on NT surfaces than Ti surfaces after 7 days for 2,500 and 3,750 
cells/well densities, however, ADSC proliferation for the higher cell density (5,000 
cells/well) experienced lower cell count on larger NT surface. The percent increase in cell 
count from day 1 to day 7 revealed the 2,500 cell density displayed a larger percent 
increase than 3,750 and 5,000 cell densities (Figure 3.3). The lower cell density may 
perform better due to more space for the cells to stretch, expand, and elongate which is 
an important part of cell division and differentiation. 
Morphological analysis of cells is important in order to study the cellular 
organization, the physiological state of the cells, and the cell–surface interaction. The 
morphology of ADSC was investigated using SEM images of the surfaces after 1, 4, and 
7 days of proliferation in growth media. Images of ADSC on the surfaces were only 
acquired for the 2,500 cells/well density as it was determined to be the optimal cell density 
(Figure 3.7). From the images it is clear that the ADSC were well spread across the 
surfaces after 7 days of culture. ADSC on the Ti are not as elongated as they are on the 




Figure 3.7 Scanning electron microscopy images of adipose-derived stem cells after 1, 4, and 7 days of proliferation at 100x (scale bar 100µm) and 







The images also revealed long filopodia protruding from the ADSC on all the 
surfaces (Arrows in high magnification SEM images Figure 3.7). Filopodia are actin-rich 
protrusions that play a significant role in topography sensing, migration, and cell-cell 
interaction [16,17]. Elongation is determined by the initial protein adsorption and protein 
adsorption is dependent on the surface characteristics. Studies have shown that cells 
cultured on smaller NT easily adhered to the surface because of the large number and 
thorough distribution of protein nanoparticles already covering the whole surface of the 
NT, however, proteins on larger NT only adhered sparsely to the surface due to the 
presence of large empty spaces around the NT. Thus, cells on the larger NT must expand 
further to find a protein-deposited surface, causing them to extend their filopodia across 
larger areas and eventually forming an elongated shape [18,19].   
 
3.3 Conclusions 
The purpose of this study was to determine the effect of nanotube (NT) size and 
cell density on the adhesion and proliferation of human adipose-derived stem cells 
(ADSC). Week long proliferation of ADSC on NT and Ti surfaces presented elongated 
cells on NT surfaces and ADSC cell count was greater than Ti on all nanotube surfaces 
after 7 days proliferation.  The optimal cell density was 2,500 cells/well because it allowed 
the cells to proliferate more fully and elicited a higher increase in viability and cell count 
on nearly all surfaces. The smaller diameter nanotubes, NT30 and NT45, were better for 
ADSC proliferation as they elicited higher cell counts after day 7. This study confirms that 
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CHAPTER 4  
EVALUATION OF THE EFFECT OF TITANIA NANOTUBES ON THE 




Stem cells are unspecialized cells capable of renewing themselves through self-
renewal and can be induced to become specialized cells within specific tissue. In all 
tissues of the body, stem cells become activated when an injury occurs and are recruited 
to the injury site to aid in the tissue repair process [1]. When a biomaterial is implanted, 
the body reacts similar to an injury and stem cells are recruited to the implant site. Since, 
stem cells play an important role in tissue repair in the body, their interaction with 
biomaterials is critical for long term success of medical devices. Adipose-derived stem 
cells (ADSC) are mesenchymal stem cells obtained from adipose tissue and have the 
ability to differentiate into osteoblasts, bone forming cells [2]. It is important for osteoblasts 
to be present and active on an implant surface to help create a structural connection 
between the living bone and the implant, or osseointegration. Thus, studying the 
differentiation of stem cells into osteoblasts and their subsequent activity level on an 
implant surface in vitro gives a first glimpse of the potential of that biomaterial surface as 
an orthopedic implant. 
This chapter addresses specific aim 3. In this chapter the osteogenic differentiation 
of adipose-derived stem cells (ADSC) for three weeks on titanium (Ti) and nanotube (NT) 
surfaces is evaluated and discussed. Differentiation markers of alkaline phosphatase 
(ALP) activity, non-collagen protein osteocalcin (OCN), and calcium deposition to confirm 
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and analyze the differentiation of ADSC on the NT and Ti surfaces are discussed. 
Immunofluorescence staining is performed to examine production of osteocalcin by the 
differentiated ADSC. Scanning electron microscopy is also utilized to visualize 
differentiated cells and mineral deposition.  
 
4.1 Methods and Materials 
4.1.1 ADSC Differentiation 
After 7 days of proliferation on the surfaces, osteogenic differentiation was induced 
using osteogenic media; growth media supplemented with 10 nM dexamethasone, 5.4 
mM β–glycerolphosphate, and 300 µM ascorbic acid.  Differentiation media changes were 
done every 2-3 days.   
To confirm osteogenic differentiation and to determine the level of activity of the 
differentiated ADSC, three assays were performed: alkaline phosphatase (ALP) activity, 
total protein content (micro BCA assay), and calcium concentration.  After 7, 14 and 21 
days of induced osteogenesis, the surfaces were washed with PBS and transferred to a 
new well plate.  The ADSC were lysed with 500 µl of 0.2% w/v Triton X-100 in sterile DI 
water for 20 minutes (while shaken at 150 rpm) to remove all proteins from the surfaces.  
To determine total protein content, 150 µL of Triton-protein mixture was placed in 
a 96 well plate with 150 µL of working reagent made from micro BCA protein assay kit 
(Thermo Scientific).  The well plate was covered with foil and incubated at 37 °C for two 
hours.  Absorbance was read at 562 nm.  The total proteins expressed by ADSC were 
determined from a standard absorbance curve versus known concentration of albumin 
run in a parallel experiment. 
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To assess ALP activity, 50 µL of Triton-protein mixture was placed in a 96 well 
plate and 150 µL of working reagent made from QuantiChromTM Alkaline Phosphatase 
Assay Kit (BioAssay Systems) was added using a multichannel pipette.  Absorbance was 
read at 405 nm and then repeated 4 minutes later.  
To quantify calcium deposition on each surface a commercially available calcium 
reagent test (Teco Diagnostics) was used. After cell lysis, the surfaces were soaked in 
500 µl of 6 N HCl for two hours to dissolve deposited calcium. After two hours, 20 µl of 
the calcium-acid solution was removed to a new well plate and 1 ml of working reagent 
was added. The absorbance of the calcium–acid solution was measured at 570 nm and 
was converted to concentration using the absorbance of a reference calcium solution. 
The osteogenic differentiation of ADSCs was confirmed through 
immunofluorescent staining of the cells and the protein osteocalcin. After 7, 14, and 21 
days of induced osteogenesis, differentiation media was removed and surfaces were 
washed twice with warm PBS and then moved to a new well plate. The surfaces were 
fixed in 3.7 wt% formaldehyde in PBS for 15 min at room temperature, followed by three 
washes (5 min per wash) with PBS. Adhered ADSC were permeabilized by incubation in 
1% Triton-X in PBS for 3 minutes and rinsed with PBS. After transferring surfaces to a 
new well plate, non-specific sites were blocked by incubating the ADSC in 10% bovine 
serum albumin (BSA) (Sigma) for 30 minutes. Blocking serum was removed and 
osteocalcin primary antibody (Santa Cruz Biotechnology) was added at the dilution of 
1:100 in 1% BSA for 60 minutes at room temperature, followed by three washes (5 min 
per wash) with PBS. Secondary antibody FITC (Santa Cruz Biotechnology) was applied 
at the dilution of 1:200 in 1% BSA for 45 minutes, followed by one wash with PBS. The 
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ADSC were then incubated in Rhodamine and DAPI nuclear stain with the same 
procedure discussed in ADSC adhesion and proliferation section. Surfaces were rinsed 
twice with PBS and imaged with a fluorescence microscope (Zeiss). The osteocalcin 
present was determined by calculating percentage area (ImageJ software) coverage of 
stained osteocalcin from the fluorescence images at 10x magnification. 
The morphology and mineral deposition of ADSC on Ti surfaces was investigated 
using SEM images of the surfaces after 21 days of induced osteogenesis in differentiation 
media. SEM fixing was performed with the same procedure discussed in Chapter 3. A 
gold coating of 10 nm was utilized and images were taken at 10 kV.  Dispersive X-Ray 
Spectrometry (EDS) was utilized to confirm calcium and phosphorous mineral deposition 
after 21 days.  Gold coating was not done before performing EDS on the surfaces as the 
gold peak interferes with the phosphorous peak during spectrum analysis.  
 
4.1.2 Statistical analysis  
All studies were performed with nmin = 3 for qualitative analyses and nmin = 5 for 
quantitative analyses. Minitab software was used to conduct the statistical analysis. The 
statistical differences were compared using one-way ANOVA analysis (p < 0.05) with a 
post-hoc Tukey's HSD (honest significant difference) test.  All data is shown as the 
average ± standard errors. 
 
4.2 Results and Discussion 
Since titanium implants still experience loosening and eventual failure [3–6],  
implants with nanostructured surfaces could help improve their fixation to the surrounding 
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bone tissues [7–11]. By fully understanding the effect of nanostructure size on the 
osteogenic differentiation of stem cells, implants could be specifically designed to achieve 
the optimal stem cell response from the tissue in which they are implanted. In this chapter, 
the effect of nanotube (NT) size on the differentiation of human adipose-derived stem 
cells (ADSC) was investigated.  
Different NT surfaces were fabricated using anodization at 30 V, 45 V and 60 V as 
described in Chapter 2. After 7 days of proliferation on NT and Ti surfaces, osteogenesis 
of adhered ADSC was induced using growth media supplemented with 10 nM 
dexamethasone, 5.4 mM β–glycerolphosphate, and 300 µM ascorbic acid.  ADSC were 
allowed to proliferate on the surfaces for 7 days because that is when they reach 80–90% 
confluence, which is the optimal concentration to induce differentiation [12]. The 
concentrations of dexamethasone, β–glycerolphosphate, and ascorbic acid were chosen 
based on their proven ability to induce osteogenic differentiation in ADSC [12,13].  
Alkaline phosphatase (ALP) is an enzyme found throughout the body and plays an 
integral role in the health of the liver and bone. In bone, ALP activity is associated with 
calcification because activity peaks just before mineralization begins. It is believed that 
high ALP leads to increased levels of inorganic phosphate, one of the components of 
apatite, the mineral phase of bone [8,14]. Thus, ALP activity is used as an early marker 
of osteoblast differentiation and hence was measured after 7, 14, and 21 days of induced 
osteogenesis.  The ALP activity was normalized with total protein content of the cells to 
take into account the differences in number of cells on Ti and NT surfaces. Total protein 
content secreted by differentiated ADSC was also measured after 7, 14, and 21 days of 
induced osteogenesis using a micro BCA assay kit. ALP activity on NT30 and NT45 is 
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significantly higher (Tukey’s HSD p < 0.05) than Ti after 14 days, but after 21 days ALP 
activity is back down for all surfaces and there is no significance between Ti and NT 
surfaces after 21 days (Figure 4.1).   
 
Figure 4.1 Alkaline Phosphatase Activity (ALP) normalized by total protein content (Micro BCA assay). ALP 
and BCA assays were performed 7, 14 and 21 days after induced osteogenesis of ADSC. When statistically 
comparing between weeks of the same treatment, Ti and NT60: no significance between weeks; NT30: 
Day 7 is significantly different from Day 14 and Day 21; NT45: Day 7 is significantly different from Day 14. 
When statistically comparing between treatments on the same week, Day 7: Ti is significantly different from 
NT45 and NT60; Day 14: Ti is significantly different from NT30 and NT45, also NT60 is significantly different 
from NT30; Day 21: no significance between treatments. (Tukey’s HSD p<0.05) Full statistical analysis 
found in Appendix I. 
 
These results are consistent with osteoblast activity in bone and calcifying 
cartilage. In early development, ALP is expressed but later in the cell development ALP 


























































Statistical significance presented in figure caption
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After 21 days, the results indicate that as the size of NT increases, ALP activity decreases 
suggesting slower osteoblast enzyme function. Several studies have found that ALP is 
higher on nanostructured surfaces [7,15–18], compared to Ti surfaces, however studies 
that compare ALP activity on different sizes of NT have varied results with some finding 
larger NT with higher ALP [7], and others finding that the smaller NT had higher ALP 
[17,19].  Clearly the size of NT is not the only factor that affects the ALP activity.  The type 
of cell lineage used, concentrations of inducing chemicals in differentiation media, and 
the concentration of the cells cultured may also affect ALP and hence it is difficult to 
correlate ALP activity directly to NT size. 
In order to deposit organic matrix necessary for mineralization, osteoblasts will also 
secrete collagen proteins, non-collagen proteins (e.g. osteocalcin, osteonectin, and 
osteopontin), and proteoglycan [20].  Osteocalcin (OCN) is a small molecular weight 
protein produced by osteoblasts that aids in mineralization and is considered a late 
marker of differentiation. In this study, immunofluorescent staining was used to visualize 
how OCN is distributed on the NT and Ti surfaces and was performed after 7, 14, and 21 
days of induced osteogenesis (Figure 4.2). The immunofluorescent images show that 
OCN is well distributed across the surfaces and increasing each week. OCN proteins are 
small circular dots and some are circled in each image in Figure 4.2. OCN area coverage 
was calculated from immunofluorescent images of each surface using ImageJ software 







Figure 4.2 Immunofluorescent images of adipose-derived stem cells taken at 20x magnification after 7, 14 and 21 days of induced osteogenesis 








Figure 4.3 Percentage area coverage of osteocalcin normalized by total protein content (Micro BCA assay) 
after 7, 14 and 21 days induced osteogenesis. When statistically comparing between weeks of the same 
treatment, Ti: all weeks are significantly different from each other; NT60: Day 7 is significantly different from 
Day 14 and Day 21; NT30 and NT45: Day 21 is significantly different from Day 7 and Day 14. When 
comparing between treatments on the same week, Day 7: NT30 is significantly different from Ti, NT45 and 
NT60; Day 14: no significance between treatments; Day 21: NT30 and NT45 are significantly different from 
Ti and NT60. (Tukey’s HSD p<0.05) Full statistical analysis found in Appendix I. 
 
Results indicated that NT30 and NT45 had the highest average osteocalcin after 
21 days. All surfaces displayed higher OCN after 21 days which is to be expected since 
OCN is a late marker of differentiation.  Other studies have also found higher osteocalcin 
on nanosurfaces than on Ti [26]-[27].  However, in this study the larger NT displayed 
lower percentages of osteocalcin after 21 days suggesting that osteoblasts perform their 
function better when adhered to smaller NT sizes. These findings are similar to other 
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found higher osteocalcin on the largest NT [18].  It should be noted that the standard 
deviations for some surfaces and days are large. (Full statistical analysis can be found in 
the caption for Figure 4.3).  
After increased ALP activity and protein secretion, the next step in the synthesis 
of bone matrix by osteoblasts is mineralization. Mineralization is when the cells produce 
hydroxyapatite which is composed of calcium and phosphorus. This occurs when the 
osteoblasts secrete enzymes that degrade the proteoglycans and phosphate-containing 
compounds causing the release of calcium and phosphate ions. The phosphate and 
calcium ions then merge to form hydroxyapatite crystals. Calcium deposited on NT and 
Ti surfaces was determined using a calcium reagent test after 7, 14, and 21 days of 
induced osteogenesis (Figure 4.4).  After 21 days all NT surfaces have significantly larger 
concentrations of calcium than the Ti surfaces. Other reports show similar findings with 
calcium mineralization being higher on nanosurfaces than on titanium [15,16,18,21,25].  
A couple of studies also comparing size of NT found that calcium deposition decreased 
as NT diameter increased [24,26]. In contrast, in this study the results reveal that ALP 
activity and OCN were lower on larger NT, however, higher calcium concentration was 
found on the larger NT.  This may be due to cells on the larger NT having more surface 
area and thus more nucleation sites available to deposit calcium. Additionally, low ALP 
activity indicates lower phosphorous production and so there may not be enough 
phosphorous ions available to merge with the calcium ions and form hydroxyapatite, 





Figure 4.4 Calcium concentration on samples 7, 14 and 21 days after induced osteogenesis determined 
using a calcium reagent test. When statistically comparing between weeks of the same treatment, for all 
treatments (Ti, NT30, NT45, and NT60) Day 7 is significantly different from Day 14 and Day 21. When 
comparing between treatments on the same week, Day 7: Ti is significantly different from NT45 and NT60; 
Day 14: Ti is significantly different from NT30, NT45, and NT60; Day 21: Ti is significantly different from 
NT30, NT45, and NT60, NT60 is significantly different from NT30. (Tukey’s HSD p<0.05) Full statistical 
analysis found in Appendix I. 
 
The morphology and mineral deposition of ADSC on NT and Ti surfaces was 
investigated using SEM images of the surfaces after 21 days of induced osteogenesis 
(Figure 4.5). After 21 days, the surfaces were almost completely covered by differentiated 
ADSC and mineralized matrix components were prevalent on both NT and Ti surfaces 
(Arrows indicate minerals in Figure 4.5). Dispersive X-Ray Spectrometry (EDS, Oxford 
instruments X-Max) was also utilized after 21 days of induced osteogenesis and 
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surfaces.  These depositions may be hydroxyapatite which is a mineral produced by 
osteoblasts and composed of calcium and phosphorus. SEM images also showed that 
the NT were still intact and not affected by three weeks of cell culture. 
 
4.3 Conclusions 
The goal of this study was to determine the effect of nanotube (NT) diameter on 
the differentiation of human adipose-derived stem cells (ADSC).  Three different NT 
surfaces were fabricated using anodization and week-long proliferation of ADSC on NT 
and Ti surfaces was performed before osteogenesis was induced using osteogenic 
media. Results showed that ADSC differentiated and performed better on NT surfaces 
than Ti surfaces.  Additionally, the size of titania NT also affected the osteogenic 
differentiation of ADSC. Alkaline phosphatase activity and percent of osteocalcin declined 
as NT diameter increased, however, calcium concentration increased as NT diameter 
increased. SEM revealed widespread mineral deposition on all Ti and NT surfaces. This 
study confirms that NT surfaces promote osteogenic differentiation of human ADSC and 





Figure 4.5 SEM images of differentiated adipose-derived stem cells and mineral deposition after 21 days of induced osteogenesis at 1000x 
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CHAPTER 5  





The need for joint replacement will continue to grow and increase significantly in the 
coming decades due to the aging population. Unfortunately, many joint implants 
experience failure after 10-15 years requiring revision surgery. Since joint implant 
materials come into direct contact with bone it is imperative that they mimic the structure 
of bone to improve osseointegration, or the direct structural and functional connection 
between living bone and the implant surface. Improving the osseointegration of the 
implant can increase the stability of the implant, thus, reducing micro motions that cause 
loosening and lead to implant failure. Current joint implants have microscale coatings and 
texturing, however, bone is composed of both micro and nano components.  In order to 
mimic the nanostructure of bone many nanotopograhies are being studied. These 
nanostructures have been shown to improve cellular response in terms of adhesion, 
proliferation and osteogenic differentiation. However, the optimal size of nanosurfaces to 
promote cell adhesion, proliferation, and differentiation is still disputed. Titania nanotubes 
(NT) are easily fabricated on titanium surfaces using electrochemical anodization and 
have been shown to improve cellular response in vitro and improve integration in vivo.   
This thesis examined the surface characteristics of titania NT and the effect of 
nanotube size on adhesion, proliferation, and differentiation of adipose-derived stem cells 
(ADSC) in vitro. Titania NT with three different diameters were fabricated via anodization 
in an organic electrolyte solution by altering the voltage and duration of each anodization 
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process. The manner in which cells interact with a surface is largely determined by the 
proteins adhered on the surface. The surface characteristics that may affect how proteins 
interact with the surface are tube diameter and length, surface wettability, crystalline 
structure, and surface chemistry. These characteristics were evaluated and discussed for 
all three NT surfaces and titanium (Ti) control. Tube inner diameter and length of NT were 
characterized via scanning electron microscopy (SEM). Contact angle was used to 
determine wettability and revealed that all NT surfaces exhibited higher wettability than 
Ti control. Glancing angle X-ray diffraction (GAXRD) revealed all NT surfaces in this study 
exhibited high anatase content and x-ray photoelectron spectroscopy (XPS) indicated 
small percentages of fluoride present on all three NT surfaces. In conclusion, all of these 
surface characterization tests suggest that these NT surfaces should be ideal for in vitro 
cell studies and have the potential to promote cell adhesion, proliferation and 
differentiation.  
Week long proliferation studies with ADSC on NT and Ti surfaces were performed 
in vitro.  Adhesion and proliferation were investigated using a viability assay, fluorescent 
staining, and scanning electron microscope to visualize cell morphology. The studies 
revealed elongated cells on NT surfaces and ADSC count was greater on all nanotube 
surfaces than Ti after seven days proliferation.  The smaller diameter nanotubes, NT30 
and NT45, were better for ADSC proliferation as they elicited the highest cell counts after 
day seven.  
After week-long proliferation of ADSC on NT and Ti surfaces, osteogenesis was 
induced using osteogenic media. To confirm osteogenic differentiation and to determine 
the level of activity of the differentiated ADSC, three assays were performed: alkaline 
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phosphatase (ALP) activity, total protein content (micro BCA assay), and calcium 
concentration. Immunofluorescence staining to examine production of osteocalcin and 
scanning electron microscopy to visualize the cells was also performed. Results showed 
that ADSC differentiated and performed better on NT surfaces than Ti surfaces. 
Additionally, the size of titania NT altered the osteogenic differentiation of ADSC. Alkaline 
phosphatase activity and percent of osteocalcin declined as NT diameter increased, 
however, calcium concentration increased as NT diameter increased. Scanning electron 
microscopy revealed widespread mineral deposition on all Ti and NT surfaces.  
This thesis confirmed that NT surfaces promote adhesion, proliferation, and 
osteogenic differentiation of human ADSC and revealed that smaller NT performed this 
function better than larger NT.  Further studies are needed to confirm that implants with 
NT surfaces enhance osseointegration and to further define their potential to improve 
implant stability. 
 
5.2 Future Work 
Future studies should be directed into four main areas.  
1. Research into understanding the nanoscale mechanisms that affect cell 
function. Specifically looking at why cell proliferation and differentiation is 
altered on nanosurfaces and what, if any, biochemical changes occur within 
the cells due to their interaction with a nanostructured surface. 
2. Fabrication of nanotubes on titanium alloys that are commonly used in joint 




3. Mechanical testing of hip and knee implant (ASTM F1875 - 98(2014)) 
components that have a nanotube surface topography in a loading 
environment. Since joint implants experience a large range of motion and 
multiple forces it is important to determine the stability of the nanotube 
topography when placed in a simulated loading environment.  
4. In vivo animal studies using rats, dogs, goat, and/or sheep models. Initial 
studies to determine whether the osseointegration is improved by adding 
nanotubes can be done on smaller animal models such as rats.  For weight 
bearing mechanical analysis a larger animal model such as dog, goat or 









Statistical Plots and Analysis for Figure 2.3 
First, analyzing NT inner diameter for NT30, NT45, and NT60. 
 





Test for equal variances is not very good so will run ANOVA with a Tukey post hoc 











Test for Equal Variances: NT30, NT45, NT60
Multiple comparison intervals for the standard deviation, α = 0.05




Both Tukey post hoc and Games-Howell find that all three NT surface’s inner diameter 
are significantly different from each other. 
Second, analyzing NT length for NT30, NT45, and NT60. 
 




NT30 and NT45 have close enough variances, however, NT60 is not very close, but is 
within 5x of NT45 so should be ok to use an ANOVA. 










Test for Equal Variances: NT30-L, NT45-L, NT60-L
Multiple comparison intervals for the standard deviation, α = 0.05
If intervals do not overlap, the corresponding stdevs are significantly different.
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Tukey shows that all three NT surfaces are significantly different from each other. Since 
NT30 is not normal, but dependent variable is continuous, will run a Mann-Whitney (for 
non-normal sets of data) to confirm that the means of data sets are significantly different 
with the NT30. 
Mann-Whitney Test and CI: NT30-L, NT45-L  
         N  Median 
NT30-L  26  0.6780 
NT45-L  23  2.0680 
 
Point estimate for η1 - η2 is -1.4069 
95.2 Percent CI for η1 - η2 is (-1.4840,-1.2791) 
W = 351.0 
Test of η1 = η2 vs η1 ≠ η2 is significant at 0.0000 
The test is significant at 0.0000 (adjusted for ties) 
Since value is 0.000<0.05, confirms that NT30 and NT45 are significantly different from 
each other. 
Mann-Whitney Test and CI: NT30-L, NT60-L  
         N  Median 
NT30-L  26  0.6780 
NT60-L  30  3.5165 
 
Point estimate for η1 - η2 is -2.7978 
95.0 Percent CI for η1 - η2 is (-3.0690,-2.3519) 
W = 351.0 
Test of η1 = η2 vs η1 ≠ η2 is significant at 0.0000 
Confirms that NT30 and NT60 are significantly different from each other.  
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Statistical Plots and Analysis for Figure 2.4 
 
All normally distributed except NT60, but should be ok to run an ANOVA. 
 










Test for Equal Variances: Ti, NT30, NT45, NT60
Multiple comparison intervals for the standard deviation, α = 0.05




One-way ANOVA with a post hoc Tukey shows that the NT surface contact angles are 




Statistical Plots and Analysis for Figure 4.1 
 
All data sets have normal distribution. 
 


















Test for Equal Variances 
Multiple comparison intervals for the standard deviation, α = 0.05
If intervals do not overlap, the corresponding stdevs are significantly different.
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Run a one-way ANOVA with post hoc Tukey to determine significance. 
When statistically comparing between weeks of the same treatment:  
 
 




For NT30, Day 7 is significantly different from Day 14 and Day 21. 
 
For NT45, Day 7 is significantly different from Day 14.  
86 
 
When statistically comparing between treatments on the same week: 
 
For Day 7, Ti is significantly different from NT45 and NT60.  
 
For Day 14, Ti is significantly different from NT30 and NT45, also NT60 is significantly 









Statistical Plots and Analysis for Figure 4.3 
Two outliers in NT 60 Day 21 were removed prior to statistical analysis presented. 
 
Several data sets on Day 7 are not normal: Ti Day 7, NT45 Day 7, NT60 Day 7. 
 


















Test for Equal Variances
Multiple comparison intervals for the standard deviation, α = 0.05
If intervals do not overlap, the corresponding stdevs are significantly different.
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Still choosing to run a one-way ANOVA with post hoc Tukey to determine significance 
as most data sets were normal (just not Day 7) and equal variance is adequate enough 
for ANOVA. 
When statistically comparing between weeks of the same treatment: 
 









For NT60, Day 7 is significantly different from Day 14 and Day 21. 
 
When comparing between treatments on the same week: 
 
For Day 7, NT30 is significantly different from Ti, NT45 and NT60. 
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Since Ti Day 7, NT45 Day 7, and NT60 Day 7 did not have normal distributions, did a 
Mann-Whitney (used for non-normal data sets) to confirm that NT30 was significantly 
different from all the other surfaces. 
Mann-Whitney Test and CI: NT30 Day 7, Ti Day 7  
             N   Median 
NT30 Day 7  20  0.19133 
Ti Day 7    20  0.00850 
 
Point estimate for η1 - η2 is 0.17350 
95.0 Percent CI for η1 - η2 is (0.08923,0.22194) 
W = 596.0 
Test of η1 = η2 vs η1 ≠ η2 is significant at 0.0000 
The test is significant at 0.0000 (adjusted for ties) 
Since value is 0.000<0.05, confirms NT30 and Ti are significantly different. 
Mann-Whitney Test and CI: NT30 Day 7, NT45 Day 7  
             N   Median 
NT30 Day 7  20  0.19133 
NT45 Day 7  20  0.04267 
 
Point estimate for η1 - η2 is 0.11997 
95.0 Percent CI for η1 - η2 is (0.05715,0.18267) 
W = 560.0 
Test of η1 = η2 vs η1 ≠ η2 is significant at 0.0001 
Confirms NT30 and NT45 are significantly different. 
Mann-Whitney Test and CI: NT30 Day 7, NT60 Day 7  
             N   Median 
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NT30 Day 7  20  0.19133 
NT60 Day 7  14  0.01369 
 
Point estimate for η1 - η2 is 0.16293 
95.2 Percent CI for η1 - η2 is (0.07979,0.22098) 
W = 475.0 
Test of η1 = η2 vs η1 ≠ η2 is significant at 0.0000 
The test is significant at 0.0000 (adjusted for ties) 
Confirms NT30 and NT60 are significantly different. 
The Mann-Whitney also says that NT45 and Ti are significantly different and NT45 and 
NT60 are significantly different which did not show up using ANOVA. 
Mann-Whitney Test and CI: NT45 Day 7, NT60 Day 7  
             N   Median 
NT45 Day 7  20  0.04267 
NT60 Day 7  14  0.01369 
 
Point estimate for η1 - η2 is 0.02171 
95.2 Percent CI for η1 - η2 is (0.00117,0.05822) 
W = 414.0 
Test of η1 = η2 vs η1 ≠ η2 is significant at 0.0263 
Mann-Whitney Test and CI: NT45 Day 7, Ti Day 7  
             N   Median 
NT45 Day 7  20  0.04267 
Ti Day 7    20  0.00850 
 
Point estimate for η1 - η2 is 0.02256 
95.0 Percent CI for η1 - η2 is (0.00769,0.06084) 
94 
 
W = 516.0 
Test of η1 = η2 vs η1 ≠ η2 is significant at 0.0043 
The test is significant at 0.0043 (adjusted for ties) 
 
For Day 14, no significance between surfaces. 
 
Day 21: NT30 and NT45 are significantly different from Ti and NT60. 
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Statistical Plots and Analysis for Figure 4.4 
 
All data sets exhibit normal distribution except NT30 Day 7, but is not very low p-value 
so it might be fine to treat it as normal distribution. 
 
Test for equal variance looks good. So will run one-way ANOVA with post hoc Tukey, 


















Test for Equal Variances
Multiple comparison intervals for the standard deviation, α = 0.05
If intervals do not overlap, the corresponding stdevs are significantly different.
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For all treatments (Ti, NT30, NT45, and NT60) Day 7 is significantly different from Day 
14 and Day 21.  
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When comparing between treatments on the same week: 
 
For Day 7, Ti is significantly different from NT45 and NT60. 
 




For Day 21: Ti is significantly different from NT30, NT45, and NT60. Additionally NT60 
is significantly different from NT30. 
 
 
